在三阴性乳腺癌中免疫疗法耐药性的分子机制
Yiwen Zheng1, Shujin Li1, Hongchao Tang2
1The Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, China.
Frontiers in immunology
|July 10, 2023
概括
免疫疗法为三阴性乳腺癌 (TNBC) 提供了新的希望,但耐药性限制了其有效性. 这篇评论探讨了TNBC的情况.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 癌症研究 癌症研究
背景情况:
- 免疫疗法已经彻底改变了癌症治疗,包括三阴性乳腺癌 (TNBC).
- 然而,TNBC的显著异质性导致免疫治疗的反应变化,许多患者没有受益.
- 了解免疫疗法耐药性的机制对于改善患者的治疗结果至关重要.
研究的目的:
- 审查TNBC中免疫疗法耐药性的基础分子机制.
- 为了分类TNBC使用的免疫逃避策略.
- 确定TNBC免疫治疗的潜在治疗标和预测生物标志物.
主要方法:
- 文献综述侧重于TNBC中的免疫疗法耐药性.
- 免疫反应过程和逃避机制的分析.
- 讨论有助于免疫抑制瘤微环境的信号通路.
主要成果:
- TNBC免疫规避机制包括瘤特异性抗原的丧失,抗原呈现受损和免疫反应启动失败.
- 免疫关键信号通路的异常激活有助于免疫抑制瘤微环境.
- 这些因素共同导致TNBC的免疫治疗药物耐药性.
结论:
- 阐明TNBC耐药性的分子基础是开发有效治疗方法的关键.
- 识别新的点可能有助于逆转免疫疗法耐药性.
- 生物标志物研究对于选择将受益于免疫治疗的TNBC患者至关重要.
更多相关视频
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
7.3K
09:40Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
2.7K
相关概念视频
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
01:27Tumor Immunotherapy
567
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
567
01:27Cytotoxic T Cells-mediated Immune Response
985
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
985
02:17The Tumor Microenvironment
6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
02:38Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K